MDxHealth is trading at $0.18, down 5.60% after hours on October 26, 2026; no company-specific announcement explaining the decline was found. - The broad market rose during the session, so it does not clearly explain MDxHealth’s opposite-direction move. - The latest major company news was October 15: preliminary third-quarter revenue was $22.7 million, and full-year 2026 revenue guidance was suspended. That news predates this move and does not establish its cause.